🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA  ·  Read original ↗

Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).


This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.

Share: 𝕏 Twitter/X 🔗 LinkedIn View on MHRA ↗

More in Diabetes / Metabolic